International Publisher of Science, Technology and Medicine


Jeffrey Jacobson

Jeffrey Jacobson

Jeffrey Jacobson, MD
Department of Medicine, Neuroscience, and Neurovirology
Temple University, USA



Jeffrey Jacobson, MD, has completed his MD in Cornell University Medical College, New York, NY, 1977. Dr. Jacobson has been appointed as Professor of Medicine, Professor of Neuroscience and Professor in the Center for Neurovirology at the Lewis Katz School of Medicine at Temple University. Dr. Jacobson is a nationally and internationally-renowned expert in clinical research on HIV and other chronic viral infections. Dr. Jacobson has 118 peer-reviewed publications in high impact journals such as New England Journal of Medicine, Lancet, Nature Medicine, Journal of Infectious Diseases and Annals of Internal Medicine. Dr. Jeffrey M. Jacobson has extensive experience in the care and investigative study of patients with HIV, hepatitis B, and hepatitis C infection. Recently, he has been studying long-acting parenteral antibody and other therapies against HIV infection. He has chaired numerous clinical research studies involving pathogenesis, pharmacokinetics, and treatment in and outside the NIH-sponsored AIDS Clinical Trials Group. In addition, he has chaired several ACTG committees, including the Immunology Committee and the Translational Research and Drug Development Committee, and has been a member of the Scientific Agenda Steering Committee of the ACTG. He has co-chaired the Long Acting Drug Task Force in the ACTG, and currently serves as chair of the Micro-biome Focus Group and co-chair of the Therapeutic Vaccination Focus Group.

Research Interest

Jeffrey Jacobson particular clinical interests are immunology and immuno-pathogenesis of HIV infection, including vaccine and other immune- and gene-based therapies.


About Drunkard and the Keys which were Not Found
Editorial:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000e101
Alexander B Poletaev and Majia H Nadesan
Abstract  |   Full-text  |   PDF  |  
New Ways to Design Vaccines: Nanodelivery, Cancer Vaccines and Systems Biology
Editorial:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000e102

Ales Prokop

Abstract  |   Full-text  |   PDF  |  
Current Challenges for the Anti-Devil Facial Tumor Disease (DFTD) Vaccine Development
Editorial:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000e103
Noah Isakov
Abstract  |   Full-text  |   PDF  |  
Enhancement of Infection by Pre-Existing Non-Neutralizing Antibodies to Cross-Reactive Flaviviruses: Ramifications for Vaccination against Dengue and Zika
Commentary:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000101
Andrew W Taylor-Robinson
Abstract  |   Full-text  |   PDF  |  
Vaccine Related Myocarditis
Review Article:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000102
Manasa B, Harshita T and Mounika Y
Abstract  |   Full-text  |   PDF  |  
izmit escort sex geschichten escort bayan porno sikis adult porno pornolar